Skip to main content
OpenTrials

Clinical trial condition

Unresectable

Explore clinical trials studying Unresectable. Study availability and eligibility vary by location and protocol.

10 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Unresectable trial results

Recruiting

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

NCT06678659

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • City of Hope Duarte, California, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • SCRI Oncology Partners - PPDS Nashville, Tennessee, United States
  • START Mountain Region West Valley City, Utah, United States
View Trial Details
Recruiting

PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC

NCT06102057

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Universitätsklinik Carl Gustav Carus der Technischen Universität Dresden Dresden, Germany
  • Universitätsklinikum Essen - Klinik für Strahlentherapie Essen, Germany
  • Medical Center - University Of Freiburg, Department of Radiation Oncology Freiburg im Breisgau, Germany
  • Universitätsmedizin Göttingen, Department for Radiotherapy and Radiooncology Göttingen, Germany
View Trial Details
Completed

Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC

NCT03822351

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Research Site Anaheim, California, United States
  • Research Site Duarte, California, United States
  • Research Site Sacramento, California, United States
  • Research Site New Haven, Connecticut, United States
View all 73 locations
View Trial Details
Completed

Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients

NCT00952003

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Universitätsklinik Innsbruck Innsbruck, Austria
  • A.ö. Landeskrankenhaus Leoben Leoben, Austria
  • Krankenhaus der Stadt Linz Linz, Austria
  • Universitaetsklinik f. Innere Medizin III Salzburg, Austria
View Trial Details
Active, Not Recruiting

A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

NCT03093922

Conditions
Carcinoma, Carcinoma, Transitional Cell, Locally Advanced, +5 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details

Related conditions